Latest stories on CMPS
Compass Pathways: The Psilocybin Biotech Leader With Strong Momentum
Seeking Alpha73 · bullishproduct/pr
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners
Stocktwits News56 · neutralanalyst
B.Riley reiterates Compass Pathways stock rating citing launch setup
Investing.com Analyst Ratings56 · neutralanalyst
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too?
Stocktwits News73 · bullishm&a
COMP360 Support in PTSD Trial: Study Finds Minimal Interaction Distinct from Traditional Psychotherapy
July 16, 2026
MarketChameleon59 · neutralproduct/pr
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
Yahoo Finance63 · neutralanalyst
CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data
Stocktwits News71 · bullishproduct/pr
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
Seeking Alpha73 · bullishproduct/pr
Compass Pathways upgraded at Evercore after latest data for psychedelic therapy
Seeking Alpha63 · neutralanalyst
Compass Pathways Phase 3 COMP006 Data Review
Seeking Alpha50 · neutralgeneral
CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing
Stocktwits News63 · neutralanalyst
COMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile in Depression Transcript
Seeking Alpha59 · neutralproduct/pr
Why Psychedelics-Tied Compass Pathways Reversed Its Premarket Losses
Investors.com48 · neutralgeneral
4 stocks to watch on Tuesday: CMPS, CRM, SNPS, ADSK
Seeking Alpha50 · neutralgeneral
Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For Its Much-Awaited Depression Therapy
Stocktwits News73 · bullishproduct/pr
COMP360 Achieves Rapid and Lasting Results in Treatment-Resistant Depression—39% Show Meaningful Response at Six Months
July 7, 2026
MarketChameleon78 · bullishproduct/pr
Compass gains on new late-stage trial data for psychedelic therapy in depression
Seeking Alpha67 · bullishproduct/pr
Compass Pathways reports positive Phase 3 depression results
TipRanks73 · bullishproduct/pr
COMPASS Pathways plc (CMPS) files 8-K
SEC 8-K50 · neutralgeneral
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile | CMPS Stock News
StockTitan63 · neutralproduct/pr
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CMPS Stock News
StockTitan50 · neutralgeneral
Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?
Yahoo Finance57 · neutralanalyst
COMPASS Pathways plc (CMPS) Fell Despite Earnings Beat and Faster Deal Closure
Yahoo Top42 · neutralearnings